Andtbacka RH, Ross M, Agarwala SS, et al. A phase II multicentre trial of HF10, oncolytic virus immunotherapy, and ipilimumab combination treatment in patients with stage IIIB-IV unresectable or metastatic melanoma. SMR 2017, abstract SMR04-2.
Positief CHMP-advies MVASI
dec 2017 | Borstkanker, Gynaecologische oncologie, Longoncologie, Maag-darm-leveroncologie, Uro-oncologie